Loading...
Last update:  October 15, 2017
12:47 +1GMT

Allergenic Molecule  Hev b 6.02Homo sapiens  
Epidemiology from Literature
CohortYearCountryTestSubjectsPositive (%)Bibliography
5.3.1 - Source Exposed (Symptoms, IgE)2008PortugalIgE5100.00020080904, Rodrigues Alves R
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2009JapanIgE14100.00020090520, Yagami A
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2009JapanSPT14100.00020090520, Yagami A
5.3.1 - Source Exposed (Symptoms, IgE)2009BelgiumIgE2281.82020091121, Ebo DG
5.2.1 - Source Exposed (Symptoms, SPT)2004SpainSPT6178.700
5.4.1 - Source Exposed (Symptoms, SPT, IgE)1998GermanyIgE11877.100
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2013BrazilIgE1172.72020130429, Bueno de Sa A
5.3.1 - Source Exposed (Symptoms, IgE)2010GermanyIgE5269.23020100423, Ott H
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2012FranceIgE9769.00020120706, Garnier L
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2006SpainIgE2365.20020060324, Sanz ML
5.4.1 - Source Exposed (Symptoms, SPT, IgE)1998FinlandIgE4261.900
5.3.1 - Source Exposed (Symptoms, IgE)2010Austria / ItalyIgE5957.62020101124, Radauer C
5.3.1 - Source Exposed (Symptoms, IgE)1996FinlandIgE4356.000
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2010Italy / Austria / Switzerland / NetherlandsIgE10129.70020101118, Bublin M
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2010Italy / Austria / Switzerland / NetherlandsIgE4825.00020101118, Bublin M
5.4.1 - Source Exposed (Symptoms, SPT, IgE)1998GermanyIgE7824.300
6.5 - Occupational Exposure2004MexicoSPT5016.000
6.5 - Occupational Exposure2012South AfricaIgE857.06020120404, Singh T
3.2.1 - Source Sensitized (IgE)2009ItalyIgE71.42020091030, Quercia O
4.1.2 - Heterologous Source Sensitized (Symptoms, SPT)2011ChinaIgE1001.00020111214, Zheng YW
1.1 - Asymptomatic2009BelgiumIgE260.00020091121, Ebo DG
3.2.1 - Source Sensitized (IgE)2009BelgiumIgE200.00020091121, Ebo DG
Developed by
Panservice